April 19, 2018 / 12:47 PM / 5 months ago

BRIEF-Onconova Presents Data On Dual Inhibitor Of Cdk4/6 + Ark5 At American Association For Cancer Research 2018 Annual Meeting

April 19 (Reuters) - Onconova Therapeutics Inc:

* ONCONOVA PRESENTS DATA ON DUAL INHIBITOR OF CDK4/6 + ARK5 AT AMERICAN ASSOCIATION FOR CANCER RESEARCH 2018 ANNUAL MEETING

* ONCONOVA THERAPEUTICS INC - RECEIVES PRODUCTIVE PRE-IND GUIDANCE FROM FDA REGARDING FIRST-IN-CLASS COMPOUND ON 123300

* ONCONOVA THERAPEUTICS INC - DEVELOPMENT PROGRAM IS IN COLLABORATION WITH HANX BIOPHARMACEUTICALS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below